Authors: Schroder, CP Maurer, HR

Citation: Cp. Schroder et Hr. Maurer, Tributyrin enhances the cytotoxic activity of interleukin-2/interleukin-12stimulated human natural killer cells against LS 174T colon cancer cells in vitro, CANCER IMMU, 50(2), 2001, pp. 69-76

Authors: Schroder, CP Wisman, GBA de Jong, S van der Graaf, WTA Ruiters, MHJ Mulder, NH de Leij, LFMH van der Zee, AGJ de Vries, EGE

Citation: Cp. Schroder et al., Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation, BR J CANC, 84(10), 2001, pp. 1348-1353

Authors: Schroder, CP Kroesen, BJ de Leij, LFMH de Vries, EGE

Citation: Cp. Schroder et al., Purging of epithelial tumor cells from peripheral blood stem cells by means of the bispecific antibody BIS-1, CLIN CANC R, 6(6), 2000, pp. 2521-2527

Authors: Schroder, CP de Vries, EGE Muder, NH Willemse, PHB Sleijfer, DT Hospers, GAP van der Graaf, WTA

Citation: Cp. Schroder et al., Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin B, J ANTIMICRO, 43(5), 1999, pp. 741-743

Authors: Schroder, CP van der Graaf, WTA Willemse, PHB Vellenga, E de Leij, L Mulder, NH de Vries, EGE

Citation: Cp. Schroder et al., The impact of haematopoietic growth factors on supportive care in clinicaloncology: With special attention to potential tumour cell contamination inthe stem cell harvest, DEV HEMATOL, 33, 1998, pp. 81-95